{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:37:51Z","timestamp":1793288271583,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.nbd.2023.106221","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T15:53:13Z","timestamp":1688485993000},"page":"106221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Functional changes in neuronal circuits due to antibody-driven autoimmune response"],"prefix":"10.1016","volume":"184","author":[{"given":"Timo","family":"Kirschstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"K\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.nbd.2023.106221_bb0005","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1523\/JNEUROSCI.1689-21.2022","article-title":"Patient-derived anti-NMDAR antibody disinhibits cortical neuronal networks through dysfunction of inhibitory neuron output","volume":"42","author":"Andrzejak","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106221_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102262","article-title":"Kv1.1 channels inhibition in the rat motor cortex recapitulates seizures associated with anti-LGI1 encephalitis","volume":"213","author":"Baudin","year":"2022","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.nbd.2023.106221_bb0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1550059415595907","article-title":"Are there any specific EEG findings in autoimmune epilepsies?","volume":"47","author":"Baysal-Kirac","year":"2016","journal-title":"Clin EEG Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2023.106221_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","article-title":"Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings","volume":"263","author":"Baysal-Kirac","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2023.106221_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.654602","article-title":"Neural autoantibodies in cerebrospinal fluid and serum in clinical high risk for psychosis, first-episode psychosis, and healthy volunteers","volume":"12","author":"Bien","year":"2021","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.nbd.2023.106221_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnsyn.2018.00026","article-title":"Differentially altered NMDAR dependent and independent Long-term potentiation in the CA3 subfield in a model of anti-NMDAR Encephalitis","volume":"10","author":"Blome","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"issue":"9","key":"10.1016\/j.nbd.2023.106221_bb0035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1916337118","article-title":"Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis","volume":"118","author":"Br\u00e4ndle","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.nbd.2023.106221_bb0040","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1684\/epd.2021.1355","article-title":"Seizures in autoimmune encephalitis: specific features based on a systematic comparative study","volume":"23","author":"Cousyn","year":"2021","journal-title":"Epileptic Disord."},{"issue":"9","key":"10.1016\/j.nbd.2023.106221_bb0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated Encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"06","key":"10.1016\/j.nbd.2023.106221_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/epi.12276","article-title":"Autoimmunity, seizures, and status epilepticus","volume":"54 Suppl 6","author":"Davis","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2023.106221_bb0055","article-title":"Molecular disease mechanisms of human antineuronal monoclonal autoantibodies","author":"Duong","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2023.106221_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fneur.2019.00175","article-title":"Atypical autoimmune Encephalitis with neuropil antibodies against a yet unknown epitope","volume":"10","author":"Edwin Thanarajah","year":"2019","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2023.106221_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations","volume":"270","author":"Endres","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2023.106221_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/brainsci10020123","article-title":"Distinct effects of Stereotactically injected human cerebrospinal fluid containing glutamic acid decarboxylase antibodies into the Hippocampus of rats on the development of spontaneous epileptic activity","volume":"10","author":"Frerker","year":"2020","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.nbd.2023.106221_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.medcli.2017.10.015","article-title":"Encephalitis associated with antibodies against the NMDA receptor","volume":"151","author":"Guasp","year":"2018","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.nbd.2023.106221_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fncel.2016.00130","article-title":"Anti-GAD65 containing cerebrospinal fluid does not Alter GABAergic transmission","volume":"10","author":"Hackert","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106221_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fneur.2015.00136","article-title":"Interactions of human autoantibodies with hippocampal GABAergic synaptic transmission \u2013 analyzing antibody-induced effects ex vivo","volume":"6","author":"Haselmann","year":"2015","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2023.106221_bb0090","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuroscience.2009.08.032","article-title":"Neurological autoimmunity targeting aquaporin-4","volume":"168","author":"Hinson","year":"2010","journal-title":"Neuroscience."},{"issue":"2","key":"10.1016\/j.nbd.2023.106221_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0","article-title":"Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase","volume":"46","author":"Ishida","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106221_bb0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fimmu.2019.00686","article-title":"Autoimmunity after ischemic stroke and brain injury","volume":"10","author":"Javidi","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106221_bb0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ana.25552","article-title":"Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function","volume":"86","author":"Jurek","year":"2019","journal-title":"Ann. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2023.106221_bb0110","first-page":"S99","article-title":"Koexistierende Autoantik\u00f6rper haben einen Einfluss auf die klinische Pr\u00e4sentation von anti-GAD65-positiven Patienten mit neurologischer Manifestation","volume":"36","author":"Kamalizade","year":"2023","journal-title":"Clinical Epileptol"},{"key":"10.1016\/j.nbd.2023.106221_bb0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fneur.2019.00586","article-title":"Novel object recognition in rats with NMDAR dysfunction in CA1 after stereotactic injection of anti-NMDAR Encephalitis cerebrospinal fluid","volume":"10","author":"Kersten","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2023.106221_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnsyn.2020.00013","article-title":"Stereotactically injected Kv1.2 and CASPR2 Antisera cause differential effects on CA1 synaptic and cellular excitability, but both enhance the vulnerability to pro-epileptic conditions","volume":"12","author":"Kirschstein","year":"2020","journal-title":"Front. Synaptic Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2023.106221_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ana.25666","article-title":"Human cerebrospinal fluid monoclonal LGI1 autoantibodies increase neuronal excitability","volume":"87","author":"Kornau","year":"2020","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2023.106221_bb0130","article-title":"Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures","volume":"218","author":"Kreye","year":"2021","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.nbd.2023.106221_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.mayocp.2021.07.023","article-title":"Autoimmune\/paraneoplastic Encephalitis antibody biomarkers: frequency, age, and sex associations","volume":"97","author":"Kunchok","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.nbd.2023.106221_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.137031","article-title":"GluN2B inhibition rescues impaired potentiation and epileptogenicity at associational-commissural CA3 synapses in a model of anti-NMDAR encephalitis","volume":"795","author":"K\u00fcpper","year":"2023","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2023.106221_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","article-title":"Autoimmune Encephalitis","volume":"8","author":"Leypoldt","year":"2013","journal-title":"Eur. Neurol. Rev."},{"issue":"1","key":"10.1016\/j.nbd.2023.106221_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.nbd.2023.106221_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2013.01.008","article-title":"Neurons as targets for T cells in the nervous system","volume":"36","author":"Liblau","year":"2013","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.nbd.2023.106221_bb0160","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106221_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329195","article-title":"Immune epilepsies study Group of the Italian League against Epilepsy. Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy","author":"Matricardi","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.nbd.2023.106221_bb0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.it.2020.02.005","article-title":"Next-generation Neuroimmunology: new technologies to understand central nervous system autoimmunity","volume":"41","author":"Meyer Zu H\u00f6rste","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2023.106221_bb0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41836","article-title":"Human hippocampal CA3 damage disrupts both recent and remote episodic memories","volume":"9","author":"Miller","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.nbd.2023.106221_bb0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1254.022","article-title":"Autoimmune disorders of neuronal potassium channels","volume":"998","author":"Newsom-Davis","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"14","key":"10.1016\/j.nbd.2023.106221_bb0185","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.cell.2022.06.025","article-title":"Structural mechanisms of GABAA receptor autoimmune encephalitis","volume":"185","author":"Noviello","year":"2022","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.nbd.2023.106221_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1684\/epd.2014.0635","article-title":"EEG-confirmed epileptic activity in a cat with VGKC-complex\/LGI1 antibody-associated limbic encephalitis","volume":"16","author":"Pakozdy","year":"2014","journal-title":"Epileptic Disord."},{"issue":"2","key":"10.1016\/j.nbd.2023.106221_bb0195","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nn.4477","article-title":"Neural regulation of immunity: molecular mechanisms and clinical translation","volume":"20","author":"Pavlov","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106221_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroscience.2014.08.045","article-title":"Autoantibodies in traumatic brain injury and central nervous system trauma","volume":"281","author":"Raad","year":"2014","journal-title":"Neuroscience."},{"issue":"6","key":"10.1016\/j.nbd.2023.106221_bb0210","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain."},{"issue":"11","key":"10.1016\/j.nbd.2023.106221_bb0215","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/acn3.50919","article-title":"Hippocampal epileptogenesis in autoimmune encephalitis","volume":"6","author":"Romoli","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"15","key":"10.1016\/j.nbd.2023.106221_bb0220","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3390\/ijms21155295","article-title":"The functional roles and applications of immunoglobulins in neurodegenerative disease","volume":"21","author":"Sim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2023.106221_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2023.106221_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.600822","article-title":"Immovable object meets unstoppable force? Dialogue between resident and peripheral myeloid cells in the inflamed brain","volume":"11","author":"Spiteri","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2023.106221_bb0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fneur.2015.00189","article-title":"Serum from a patient with GAD65 antibody-associated limbic Encephalitis did not Alter GABAergic neurotransmission in cultured hippocampal networks","volume":"6","author":"Stemmler","year":"2015","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2023.106221_bb0240","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.nbd.2023.106221_bb0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jnnp-2021-326889","article-title":"New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres","volume":"93","author":"Uncini","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.nbd.2023.106221_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2023.106221_bb0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.03.009","article-title":"Antibodies and receptors: from neuromuscular junction to central nervous system","volume":"439","author":"Vincent","year":"2020","journal-title":"Neuroscience."},{"issue":"2","key":"10.1016\/j.nbd.2023.106221_bb0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/acn3.277","article-title":"Altered paired associative stimulation-induced plasticity in NMDAR encephalitis","volume":"3","author":"Volz","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2023.106221_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/neu.2021.29","article-title":"Anti-MOG autoantibody-associated schizophreniform psychosis","volume":"34","author":"von Zedtwitz","year":"2022","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.nbd.2023.106221_bb0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2015.12.027","article-title":"Stereotactic injection of cerebrospinal fluid from anti-NMDA receptor encephalitis into rat dentate gyrus impairs NMDA receptor function","volume":"1633","author":"W\u00fcrdemann","year":"2016","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.nbd.2023.106221_bb0275","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2011.09.019","article-title":"Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients","volume":"45","author":"Zhang","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.nbd.2023.106221_bb0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4103\/1673-5374.355742","article-title":"Anti-IgLON5 disease: a novel topic beyond neuroimmunology","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612300236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612300236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T10:38:56Z","timestamp":1729766336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612300236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":55,"alternative-id":["S096999612300236X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106221","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional changes in neuronal circuits due to antibody-driven autoimmune response","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106221"}}